Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial. Cromer D, Reynaldi A, Steain M, Triccas JA, et al. Clin Infect Dis 2022 Feb 1. pii: 6518223. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cromer D, Reynaldi A, Steain M, Triccas JA, et al. Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial. Clin Infect Dis 2022 Feb 1. pii: 6518223. doi: 10.1093.
PMID: 35100611